Skip to main content

Blood pressure medication recalled over possibly containing cancer-causing 'impurity'

A Lupin Pharmaceuticals Inc. blood pressure medication is being recalled by the U.S. Food and Drug Administration (FDA) for potentially containing a "probable human carcinogen."
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.